Key Insights

Highlights

Success Rate

60% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 85/100

Termination Rate

15.4%

2 terminated out of 13 trials

Success Rate

60.0%

-26.5% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed with results

Key Signals

60% success

Data Visualizations

Phase Distribution

7Total
Not Applicable (6)
P 1 (1)

Trial Status

Unknown4
Completed3
Terminated2
Recruiting2
Enrolling By Invitation1
Withdrawn1

Trial Success Rate

60.0%

Benchmark: 86.5%

Based on 3 completed trials

Clinical Trials (13)

Research Network

Activity Timeline